Showing 670 – 680 of 1304 results
-
ZipRecruiter Inc Initiation
William Blair initiated research coverage of ZipRecruiter, Inc. (ZIP $20.64). ZipRecruiter is a leading online hiring platform for small and medium-size businesses that streamlines the recruiting process for employers, offering reseller programs, ATS integrations, and an email alert program.
-
MediaAlpha Inc Initiation
William Blair & Company initiated research coverage of MediaAlpha, Inc. (MAX $39.82), a digital customer-acquisition platform for the insurance industry.
-
Alkami Technology Inc Initiation
William Blair initiated research coverage of Alkami Technology, Inc. (ALKT $41.93). Alkami provides a cloud-based digital banking platform, primarily for credit unions and banks, that helps financial institutions embrace digital transformation.
-
Workiva Inc Initiation
William Blair & Company initiated research coverage of Workiva Inc. (WK $91.16). Workiva provides the world’s leading connected reporting and compliance platform to enterprise customers on its cloud native infrastructure.
-
Hydrofarm Holdings Group Inc Initiation
William Blair & Company initiated research coverage of Hydrofarm Holdings Group, Inc. (HYFM $50.43). Hydrofarm is a leading branded hydroponics company with innovative product solutions and a comprehensive distribution platform serving the controlled environment agriculture (CEA) market.
-
BigCommerce Holdings Inc Initiation
William Blair & Company initiated research coverage of BigCommerce Holdings, Inc. (BIGC $64.65), which provides a SaaS platform that powers branded e-commerce stores.
-
SOC Telemed Inc Initiation
William Blair & Company initiated research coverage of SOC Telemed, Inc. (TLMD $8.15), one of the industry’s largest providers of telehealth solutions for the acute-care marketplace. The company focuses on three primary specialties, teleneurology, telepsychiatry, and teleICU, and has partnerships with approximately 850 facilities across the United States, including 18 of the top 25 acute-care chains in the country.
-
Translate Bio, Inc. Initiation
William Blair & Company initiated research coverage of Translate Bio, Inc. (TBIO $17.45), a clinical-stage biopharmaceutical company focused on developing its proprietary mRNA therapeutic platform (MRT) to treat disorders with unmet need.
-
Acutus Medical Inc Initiation
William Blair & Company initiated research coverage of Acutus Medical, Inc. (AFIB $30.96), a medical device company with a novel non-contact mapping technology for cardiac ablation and a broad portfolio of electrophysiology tools.
-
Biodesix Inc Initiation
William Blair & Company initiated research coverage of Biodesix, Inc. (BDSX $16.06), a diagnostic company focused on development and commercialization of tests used in risk stratification for lung nodules and to aid in the treatment for lung cancer patients.